Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells
Sara A. Byron(Translational Genomics Research Institute), Douglas Yee(University of Minnesota Medical Center)
Cited by 118
Related Papers
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
|JAMA Oncology|2020|707
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
|Cancer Cell|2021|330
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer
|JAMA Oncology|2020|225
MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial
|Journal of Clinical Oncology|2020|113
The IGF Pathway Regulates ERα through a S6K1-Dependent Mechanism in Breast Cancer Cells
|Molecular Endocrinology|2011|105